Legendary licenses

Scienmag

Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases

Scienmag

announce that the Wyss Institute’s affinity-based, multiplexed, electrochemical sensing technology, eRapid, has been licensed to the startup. The license, coordinated by Harvard’s Office of Technology Development (OTD), grants StataDX exclusive worldwide access to […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biogen licenses a stroke drug from Japanese drugmaker TMS

Bio Pharma Dive

The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed

Should e-cigarettes be licensed as medicines?

Scienmag

Latest News Ecigarettes licensed MedicinesNicholas Hopkinson at Imperial College London welcomes the move, saying this will give doctors another means to help smokers quit. E-cigarettes are currently regulated as consumer products so cannot be promoted as smoking cessation aids, he explains. Yet a Cochrane review already supports existing e-cigarettes as a smoking cessation aid, as does recently updated guidance […].

Purdue invention to improve health and welfare of farrowing sows is licensed to Canadian company

Scienmag

and WINNIPEG, Manitoba — A patented Purdue University invention designed to cool sows and lower their respiration rate while farrowing has been licensed to Innovative Heating Technologies for further beta testing and commercialization. WEST LAFAYETTE, Ind.,

Harvard Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics to facilitate infectious and immune disease and cancer diagnostics

Scienmag

announced that the Institute’s electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Medicine & Health Antisoma cancer Diagnostics Disease eRapid facilitate Harvard immune infectious Institutes licensed sensor technology therapeutics Wyss

NIH licenses COVID-19 technologies to WHO-backed program

Bio Pharma Dive

The agreement, which covers three experimental vaccines as well as several key patents, will be royalty free for products sold in 49 low-income countries

LG Chem Renews License Triggering Payment to Avacta

BioTech 365

LG Chem Renews License Triggering Payment to Avacta LG Chem Renews License Triggering Payment to Avacta LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme LONDON & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc … Continue reading → Business Wire

Merck agrees to license COVID-19 pill widely through pact with patent group

Bio Pharma Dive

The deal with the Medicines Patent Pool is meant to increase access in lower-income countries to molnupiravir, an experimental drug that could become the first oral treatment for COVID-19

Ignis Health licenses telehealth roadmap from the Medical University of South Carolina

Scienmag

Technology and Engineering Biotechnology Health Care Systems/Services Health Professionals Information Management/Tracking Systems Licenses/Patents Management Science/Operations Research Medicine/Health Technology Transfer Telecommunications

Biohaven stocks up on experimental drugs with new acquisition, licensing deal

Bio Pharma Dive

Separate agreements with Channel Biosciences and Bristol Myers Squibb give Biohaven access to experimental treatments for spinal muscular atrophy and for epilepsy

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Bio Pharma Dive

Antares Pharma's auto-injector technology is of particular interest to Halozyme, which believes that the various markets to which it could be applied represent billions of dollars in potential sales

BeiGene Announces Acceptance of Supplemental Biologics License Application in China for Anti-PD-1 Inhibitor Tislelizumab

BioTech 365

Companies Enter Licensing Agreements to Expand Gene Therapy Programs

BioSpace

Takeda entered into a licensing pact with Poseida, Spark entered into a licensing agreement with CombiGene AB, while BridgeBio Pharma announced plans for its second annual R&D Day

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

Genmab Commences New Arbitration Under License Agreement With Janssen

BioTech 365

Genmab Commences New Arbitration Under License Agreement With Janssen Genmab Commences New Arbitration Under License Agreement With Janssen Company Announcement COPENHAGEN, Denmark; June 9, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced a new arbitration under … Continue reading → GlobeNewswire

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction

BioTech 365

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in China … Continue reading → GlobeNewswire

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

BioTech 365

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 Human Immunology Biosciences (HIBio) is a biotechnology company focused on developing precision … Continue reading → Business Wire

Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II

BioSpace

A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides

U.S. FDA Licenses Certara’s Immunogenicity Simulator

BioTech 365

FDA Licenses Certara’s Immunogenicity Simulator U.S. FDA Licenses Certara’s Immunogenicity Simulator Affirms the advancements of innovative biosimulation technology and its growing impact in R&D PRINCETON, N.J., 23, 2022 (GLOBE NEWSWIRE) — Certara, Inc. Nasdaq: CERT), a global leader … Continue reading → GlobeNewswire

VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma

BioTech 365

Announces License Agreement With Scandinavian Biopharma VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma Scandinavian Biopharma has obtained a global license for VaxAlta Inc.’s VaxAlta Inc.

The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation

Scienmag

Bill & Melinda Gates Medical Research Institute to develop formulation -AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES- LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement […].

Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2 Activator

BioTech 365

Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2 Activator Kuria Therapeutics and SCOHIA PHARMA Announce Strategic Licensing Agreement for Ophthalmic and Dermal Rights to SCO-116, A Novel Nrf2 Activator … Continue reading → Business Wire

Avacta Signs Diagnostic Licensing Deal with Biokit

BioTech 365

Celogics License in NEXEL’s Cardiosight-S for Global Distribution

BioTech 365

Celogics License in NEXEL’s Cardiosight-S for Global Distribution Celogics License in NEXEL’s Cardiosight-S for Global Distribution SEATTLE–(BUSINESS WIRE)–Celogics, a U.S.-based based manufacturer of human iPSC-derived cell products for therapeutics development and life sciences research, today announced the exclusive licensing of NEXEL’s … Continue reading → Business Wire

Heritage Granted Health Canada Research License

BioTech 365

Heritage Granted Health Canada Research License Heritage Granted Health Canada Research License TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

iXensor Receives Strategic Investment from Rohto Pharmaceutical with A Separate Technology Licensing Agreement

BioTech 365

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA

BioTech 365

Bioasis and Neuramedy Enter into Research Collaboration and License Agreement

BioTech 365

Bioasis and Neuramedy Enter into Research Collaboration and License Agreement Bioasis and Neuramedy Enter into Research Collaboration and License Agreement NEW HAVEN, CONN., U.S.A., May 10, 2022 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. TSXV:BTI.V; OTCQB:BIOAF), (the “Company or “Bioasis”) a … Continue reading → GlobeNewswire

Ligand and GSK Expand Global Collaboration and License Agreement

BioTech 365

Ligand and GSK Expand Global Collaboration and License Agreement Ligand and GSK Expand Global Collaboration and License Agreement Ligand to receive an upfront payment of $10 million Further leverages the Icagen ion-channel discovery technology to target neurological diseases EMERYVILLE, Calif.–(BUSINESS

MHRA licenses Ryeqo for symptoms of uterine fibroids

Pharma Times

First oral GnRH antagonist to be licensed in Great Britain for these women

Akili adds to ADHD gaming range with £37m TALi licensing deal

Pharma Phorum

Akili already has the first and only FDA cleared video game-based digital therapeutic (DTx) for children with attention-deficit hyperactivity disorder (ADHD), but is looking to add to its range via a licensing deal with Australia’s TALi Digital. .

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

BioTech 365

Exelixis and BioInvent Establish Exclusive Option and License Agreement to Develop Novel Antibody-Based Immuno-Oncology Therapies

BioTech 365

Health Canada approves Eurofins CDMO Alphora Inc.’s Standard Processing License for Synthetic Phytocannabinoids

BioTech 365

s Standard Processing License for Synthetic Phytocannabinoids Health Canada approves Eurofins CDMO Alphora Inc.’s s Standard Processing License for Synthetic Phytocannabinoids LUXEMBOURG–(BUSINESS WIRE)–Eurofins CDMO Alphora Inc.

The Pharma Gamechanger

Pharma Business Blog

Blog Court Decision EU German Court Decision Pharma Pharma manufacturing and import license Pharma marketing authorization Pharma wholesale distribution license Sale of pharamceuticals EU Swiss Pharma Companies

Ultimate Sports, Inc. (OTC: USPS) Enters Negotiations to Acquire a Licensed Cannabis Producer in Colombia.

BioTech 365

OTC: USPS) Enters Negotiations to Acquire a Licensed Cannabis Producer in Colombia. OTC: USPS) Enters Negotiations to Acquire a Licensed Cannabis Producer in Colombia. Ultimate Sports, Inc. Ultimate Sports, Inc. The Company will enter into Agreements with Sannabis S.A.S. and … Continue reading → GlobeNewswire

Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates

BioTech 365

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

BioTech 365

Cytiva licenses Allen Institute’s advanced machine learning technology

Scienmag

Strategic license to advance the field of 3D and live cell imaging Credit: Allen Institute Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute’s machine learning technology with Cytiva’s microscopy and image analysis systems to advance the development of cell imaging innovations.

CinFina Pharma In-Licenses Obesity Portfolio

BioTech 365

CinFina Pharma In-Licenses Obesity Portfolio CinFina Pharma In-Licenses Obesity Portfolio Four novel, once-weekly anorectic agents targeting significant weight loss CINCINNATI, Sept. 22, 2021 (GLOBE NEWSWIRE) — CinFina Pharma, LLC. CinFina”) announced today that it has signed an agreement with Janssen … Continue reading → GlobeNewswire